685TiP A phase I, multicenter trial (“KinLET”) of [177Lu]Lu-edotreotide for treatment of somatostatin receptor positive solid tumors or lymphoma, in patients two to less than 18 years of age

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 35; p. S532
Main Authors Mata Fernandez, M.C., Cohen, K.J., Melnyk, S., Rotger, A., Thevenet, T.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2024
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2024.08.751